Usana Health Sciences (USNA) Common Equity (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of Common Equity data on file, last reported at $543.6 million in Q2 2026.

• Common Equity for Q2 2026 came in at $543.6 million, up 2.6% year-over-year; the trailing twelve-month figure through Apr 2026 was $543.6 million (up 2.6% YoY), and the FY2026 annual result was $533.1 million, changed 0.19% from the prior year.
• Common Equity rose to $543.6 million in Q2 2026 per USNA's latest filing, from $533.1 million in the prior quarter.
• Over five years, Common Equity peaked at $543.6 million in Q2 2026 and troughed at $389.9 million in Q2 2022.
• A 5-year average of $481.6 million and a median of $498.6 million in 2023 frame the typical range for Common Equity.
• The sharpest annual moves came in 2022 and 2023: Common Equity decreased 10.53% in 2022, then increased 16.77% in 2023.
• A 5-year view of Common Equity shows it stood at $434.5 million in 2022, then grew by 14.44% to $497.2 million in 2023, then increased by 7.02% to $532.1 million in 2024, then retreated by 0.76% to $528.1 million in 2025, then grew by 2.93% to $543.6 million in 2026.
• Business Quant data shows USNA's Common Equity at $543.6 million in Q2 2026, $533.1 million in Q1 2026, and $528.1 million in Q3 2025.